191 related articles for article (PubMed ID: 34590675)
1. Sensitive quantification of m.3243A>G mutational proportion in non-retinal tissues and its relationship with visual symptoms.
Mullin NK; Anfinson KR; Riker MJ; Wieland KL; Tatro NJ; Scheetz TE; Mullins RF; Stone EM; Tucker BA
Hum Mol Genet; 2022 Mar; 31(5):775-782. PubMed ID: 34590675
[TBL] [Abstract][Full Text] [Related]
2. Dynamic derangement in amino acid profile during and after a stroke-like episode in adult-onset mitochondrial disease: a case report.
Fukuda M; Nagao Y
J Med Case Rep; 2019 Oct; 13(1):313. PubMed ID: 31630688
[TBL] [Abstract][Full Text] [Related]
3. Renal manifestations in adults with mitochondrial disease from the mtDNA m.3243A>G pathogenic variant.
Ferreira F; Gonçalves Bacelar C; Lisboa-Gonçalves P; Paulo N; Quental R; Nunes AT; Silva R; Tavares I
Nefrologia (Engl Ed); 2023 Dec; 43 Suppl 2():1-7. PubMed ID: 38355238
[TBL] [Abstract][Full Text] [Related]
4. One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation.
Esterhuizen K; Lindeque JZ; Mason S; van der Westhuizen FH; Rodenburg RJ; de Laat P; Smeitink JAM; Janssen MCH; Louw R
Metabolomics; 2021 Jan; 17(1):10. PubMed ID: 33438095
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation.
de Laat P; Koene S; van den Heuvel LP; Rodenburg RJ; Janssen MC; Smeitink JA
J Inherit Metab Dis; 2012 Nov; 35(6):1059-69. PubMed ID: 22403016
[TBL] [Abstract][Full Text] [Related]
6. Multimodal imaging analysis of macular dystrophy in patient with maternally inherited diabetes and deafness (MIDD) with m.3243A>G mutation.
Oishi N; Kubota D; Nakamoto K; Takeda Y; Hayashi M; Gocho K; Yamaki K; Igarashi T; Takahashi H; Kameya S
Ophthalmic Genet; 2021 Jun; 42(3):304-311. PubMed ID: 33541179
[No Abstract] [Full Text] [Related]
7. Anatomic & metabolic brain markers of the m.3243A>G mutation: A multi-parametric 7T MRI study.
Haast RAM; Ivanov D; IJsselstein RJT; Sallevelt SCEH; Jansen JFA; Smeets HJM; de Coo IFM; Formisano E; Uludağ K
Neuroimage Clin; 2018; 18():231-244. PubMed ID: 29868447
[TBL] [Abstract][Full Text] [Related]
8. Determining Mitochondrial 3243A>G Heteroplasmy Using an ARMS-ddPCR Strategy.
Xu P; Jia M; Yan J; Yuan X; Yu W; Zhou Z; Fang H; Gao F; Shen L
Am J Clin Pathol; 2022 May; 157(5):664-677. PubMed ID: 34698344
[TBL] [Abstract][Full Text] [Related]
9. The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management.
Nesbitt V; Pitceathly RD; Turnbull DM; Taylor RW; Sweeney MG; Mudanohwo EE; Rahman S; Hanna MG; McFarland R
J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):936-8. PubMed ID: 23355809
[TBL] [Abstract][Full Text] [Related]
10. Detection of low levels of the mitochondrial tRNALeu(UUR) 3243A>G mutation in blood derived from patients with diabetes.
Procaccio V; Neckelmann N; Paquis-Flucklinger V; Bannwarth S; Jimenez R; Davila A; Poole JC; Wallace DC
Mol Diagn Ther; 2006; 10(6):381-9. PubMed ID: 17154655
[TBL] [Abstract][Full Text] [Related]
11. The heart in m.3243A>G carriers.
Finsterer J; Zarrouk-Mahjoub S
Herz; 2020 Jun; 45(4):356-361. PubMed ID: 30128910
[TBL] [Abstract][Full Text] [Related]
12. De Novo Mutation of m.3243A>G together with m.16093T>C Associated with Atypical Clinical Features in a Pedigree with MIDD Syndrome.
Jiang Z; Zhang Y; Yan J; Li F; Geng X; Lu H; Wei X; Feng Y; Wang C; Jia W
J Diabetes Res; 2019; 2019():5184647. PubMed ID: 31143779
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA mutation "m.3243A>G"-Heterogeneous clinical picture for cardiologists ("m.3243A>G": A phenotypic chameleon).
Niedermayr K; Pölzl G; Scholl-Bürgi S; Fauth C; Schweigmann U; Haberlandt E; Albrecht U; Zlamy M; Sperl W; Mayr JA; Karall D
Congenit Heart Dis; 2018 Sep; 13(5):671-677. PubMed ID: 30133155
[TBL] [Abstract][Full Text] [Related]
14. The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?
Mancuso M; Orsucci D; Angelini C; Bertini E; Carelli V; Comi GP; Donati A; Minetti C; Moggio M; Mongini T; Servidei S; Tonin P; Toscano A; Uziel G; Bruno C; Ienco EC; Filosto M; Lamperti C; Catteruccia M; Moroni I; Musumeci O; Pegoraro E; Ronchi D; Santorelli FM; Sauchelli D; Scarpelli M; Sciacco M; Valentino ML; Vercelli L; Zeviani M; Siciliano G
J Neurol; 2014 Mar; 261(3):504-10. PubMed ID: 24375076
[TBL] [Abstract][Full Text] [Related]
15. MIDD or MELAS : that's not the question MIDD evolving into MELAS : a severe phenotype of the m.3243A>G mutation due to paternal co-inheritance of type 2 diabetes and a high heteroplasmy level.
de Wit HM; Westeneng HJ; van Engelen BG; Mudde AH
Neth J Med; 2012 Dec; 70(10):460-2. PubMed ID: 23230016
[TBL] [Abstract][Full Text] [Related]
16. [Mitochondrial DNA heteroplasmy of the m.3243A>G mutation in maternally inherited diabetes and deafness].
Cataldo LR; Olmos P; Valerie Smalley S; Díez A; Parada A; Gejman R; Fadic R; Santos JL
Rev Med Chil; 2013 Mar; 141(3):305-12. PubMed ID: 23900320
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Variation in m.3243A > G Mutation Produce Discrete Changes in Energy Metabolism.
McMillan RP; Stewart S; Budnick JA; Caswell CC; Hulver MW; Mukherjee K; Srivastava S
Sci Rep; 2019 Apr; 9(1):5752. PubMed ID: 30962477
[TBL] [Abstract][Full Text] [Related]
18. mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease.
Grady JP; Pickett SJ; Ng YS; Alston CL; Blakely EL; Hardy SA; Feeney CL; Bright AA; Schaefer AM; Gorman GS; McNally RJ; Taylor RW; Turnbull DM; McFarland R
EMBO Mol Med; 2018 Jun; 10(6):. PubMed ID: 29735722
[TBL] [Abstract][Full Text] [Related]
19. Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
Chakrabarty S; Govindaraj P; Sankaran BP; Nagappa M; Kabekkodu SP; Jayaram P; Mallya S; Deepha S; Ponmalar JNJ; Arivinda HR; Meena AK; Jha RK; Sinha S; Gayathri N; Taly AB; Thangaraj K; Satyamoorthy K
J Neurol; 2021 Jun; 268(6):2192-2207. PubMed ID: 33484326
[TBL] [Abstract][Full Text] [Related]
20. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
